Filter
110
Text search:
Yap,
J.
Featured
Recommendations
14
New Publications
38
Language
Document type
No document type
52
Guidelines
26
Studies & Reports
14
Manuals
6
Fact sheets
5
Training Material
4
Strategic & Response Plan
2
Situation Updates
1
Countries / Regions
Brazil
12
Mozambique
4
Global
4
India
3
Venezuela
3
Russia
3
Haiti
2
Philippines
2
Angola
2
Western and Central Europe
2
Africa
2
Guinea
1
Cameroon
1
Uganda
1
Nepal
1
Germany
1
Kenya
1
Tanzania
1
Cambodia
1
Thailand
1
Indonesia
1
Bangladesh
1
Malawi
1
Ukraine
1
South–East Asia Region
1
Paraguay
1
Asia
1
Italy
1
Authors & Publishers
Publication Years
Category
Countries
27
Clinical Guidelines
6
Public Health
5
Women & Child Health
3
Pharmacy & Technologies
3
Capacity Building
1
Key Resources
1
Toolboxes
COVID-19
32
Zika
30
Mental Health
8
NTDs
6
HIV
4
Planetary Health
4
NCDs
3
Ebola & Marburg
2
Cholera
2
Rapid Response
2
Global Health Education
2
Malaria
2
Disability
1
Refugee
1
Pharmacy
1
Health Financing Toolbox
1
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа
...
This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States. The algorithm is not intended for clinical man
...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
Actualización de las orientaciones provisionales 7 de junio de 2016
THELANCETID-D-16-00800 S1473-3099(16)30318-8
Stand 2.10.2020
Organización Mundial de la Salud. (2022). Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [recombinante] (Convidecia™) contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.
Lignes directrices provisoires actualisées 7 juin 2016
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
Actualização das orientações provisórias 7 de Junho de 2016
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem
...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co
...
